United States Vaccine Adjuvants Market by Manufacturers, States, Type and Application, Forecast to 2022
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
https://www.qyresearchgroups.com/report/united-states-vaccine-adjuvants-market-by-manufacturers-states-type-and-application-forecast-to-2022
Scope of the Report:
This report focuses on the Vaccine Adjuvants in United States market, to split the market based on manufacturers, states, type and application.
Market Segment by Manufacturers, this report covers
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Market Segment by Type, covers
Oral
Subcutaneous
Intramuscular
Others
Market Segment by Applications, can be divided into
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)
https://www.qyresearchgroups.com/request-sample/327203
There are 17 Chapters to deeply display the United States Vaccine Adjuvants market.
Chapter 1, to describe Vaccine Adjuvants Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Vaccine Adjuvants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Vaccine Adjuvants, for each state, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;
Chapter 12, Vaccine Adjuvants market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 15, to describe sales channel, distributors, traders, dealers etc.
Chapter 16 and 17, to describe Vaccine Adjuvants Research Findings and Conclusion, Appendix, methodology and data source.
